×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise
Yahoo Finance
COPENHAGEN, Denmark, May 22, 2024 – Bavarian Nordic A/S (OMX: BAVA) announced today that the Company's share capital has been increased by...
6 days ago
Bavarian Nordic announces commercial launch of mpox vaccine
CIDRAP
Bavarian Nordic announces commercial launch of mpox vaccine ... Bavarian Nordic today announced the commercial launch of its vaccine against mpox...
1 month ago
UPDATED: Bavarian Nordic begins commercial launch of mpox vaccine Jynneos in US
Fierce Pharma
After years relying on the U.S. government to stockpile and distribute Jynneos, Bavarian Nordic is launching the mpox vaccine into the...
1 month ago
Bavarian Nordic expands access to mpox vaccine in US
Pharmaceutical Technology
Jynneos is derived from the parental strain of modified vaccinia virus Ankara, which is a highly attenuated pox virus that has lost the capacity...
1 month ago
Bavarian Nordic’s Mpox Vaccine Safe, Effective at Lower Doses: Study
BioSpace
A one-fifth dose of Bavarian Nordic's mpox vaccine Jynneos can elicit a similar antibody response as its standard-dose regimen, according to...
1 month ago
Vaccine Partners Turn Rivals With First Shot for Advancing Virus
Bloomberg
Two European partners will soon be vying for dominance in a new battleground: vaccines to protect travelers against a painful viral illness...
3 weeks ago
Bavarian Nordic halts cancer vaccine program
Fierce Biotech
Bavarian Nordic ends cancer vaccine program to fully focus on profitable infectious disease range ... Bavarian Nordic may be celebrating its most...
3 months ago
Bavarian Nordic Hones Infectious Disease Focus by Dropping Cancer Vaccine R&D
MedCity News
Bavarian Nordic's cancer vaccine candidate was developed with the same proprietary platform technology that yielded its other vaccines,...
3 months ago
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program and Termination of Share Buy-Back ...
Yahoo Finance
COPENHAGEN, Denmark, May 21, 2024 – Bavarian Nordic A/S (OMX: BAVA) announces that the share buy-back program, which was announced and...
6 days ago
Bavarian Nordic’s revenue soars post-mpox outbreaks
Pharmaceutical Technology
Bavarian Nordic reported a preliminary revenue of $1bn for 2023, driven by sales of JYNNEOS, its moneypox/smallpox vaccine.
3 months ago